2nd IACAPAP Special Interest Group Webinar on International Pediatric Psychopharmacology
Webinar Details
Date: 19th November 2026 (Thursday)
Time: 1 PM CET | 7 AM EST | 11 PM AEDT | 12 PM UTC
Duration: 60 minutes
Topic: Pediatric Psychopharmacology Around the World: Similar Challenges, Different Solutions — Navigating Evidence, Guidelines, and Local Practice
Clinicians around the world face many of the same challenges in pediatric psychopharmacology, including limitations in the evidence base, differences in medication regulation, availability and access, and variation in how guidelines are developed, interpreted, and applied in clinical practice.
This webinar from the IACAPAP International Pediatric Psychopharmacology Special Interest Group will explore how these factors interact in different healthcare settings. Perspectives from Sweden and Brazil will illustrate contrasting approaches to translating evidence and recommendations into local prescribing practice, including how clinicians use national and international guidelines, adapt recommendations to available treatments and healthcare systems, and address areas where evidence or guidance may be limited.
A moderated international discussion will examine the relationships among evidence, guidelines, and real-world practice; what can be learned across countries and healthcare systems; and how international collaboration can support practical, evidence-informed pediatric psychopharmacology.
Host and Chairperson
Boris Lorberg, MD, MBA
Medical Director. Lawrence Community Behavioral Health Center. Beth Israel Lahey Health Behavioral Services.
Associate Professor of Psychiatry. UMass Chan-Lahey. University of Massachusetts Chan Medical School.
Coordinator of the IACAPAP Special Interest on International Pediatric Psychopharmacology
View ProfileSpeakers
Dr Alex Vicente Spadini
Child and Adolescent Psychiatrist
Co-Chair, WPA Early Career Psychiatrists Section
President, ABENEPI-RS
Dr Alex Vicente Spadini is a Brazilian child and adolescent psychiatrist with clinical and academic interests in neurodevelopmental disorders, psychopharmacology, and international collaboration in child and adolescent mental health. He currently serves as Co-Chair of the World Psychiatric Association (WPA) Early Career Psychiatrists Section and President of ABENEPI-RS. He also holds a Master’s degree from the Federal University of Rio Grande do Sul (UFRGS).
Par J. Hoglund, MD, PhD
Child and Adolescent Psychiatrist, BUP Stockholm and Karolinska Institutet, Sweden
Par J. Hoglund, MD, PhD, is a child and adolescent psychiatrist and senior consultant at BUP Stockholm, Sweden, and is affiliated with Karolinska Institutet. He coordinates the BUP Stockholm Psychopharmacology Group, which develops and annually updates the region’s evidence-informed prescribing guideline for child and adolescent psychiatry. He is a member of the Expert Group for Mental Health of the Stockholm Region Drug and Therapeutics Committee and the Swedish National Working Group for Depression, Anxiety and OCD, and serves on the board of the Swedish Association for Child and Adolescent Psychiatry. His clinical and academic interests include pediatric psychopharmacology, evidence-based treatment implementation, and research on difficult-to-treat depression in adolescents.
Important note:
- The webinar is open to the public.
- This webinar will be conducted virtually via Zoom.
- Participation is free, but registration is required in advance. Seats are limited, and it's based on first-come, first-served. After registration, a copy of the webinar confirmation email will be sent. By registering for a webinar, consent is given for registration details to be provided to IACAPAP for webinar preparation.
- No certificate of attendance will be provided.
- IACAPAP reserves the right at all times to change, add or remove any terms without prior notice.
- IACAPAP reserves the right to make alterations to the webinar program at any time.
